Key Equity Analysts at Piper Jaffray Maintain their ‘Buy’ rating for Medidata Solutions (NASDAQ:MDSO) Shares Today. Their TP is $98.0000

May 23, 2018 - By Adrian Mccoy

Medidata Solutions, Inc. (NASDAQ:MDSO) Logo

Investors sentiment increased to 1.71 in Q4 2017. Its up 0.48, from 1.23 in 2017Q3. It increased, as 22 investors sold Medidata Solutions, Inc. shares while 61 reduced holdings. 49 funds opened positions while 93 raised stakes. 61.06 million shares or 2.97% more from 59.30 million shares in 2017Q3 were reported.

Price T Rowe Assoc Md holds 120,748 shares. Oregon Public Employees Retirement Fund holds 0.03% or 20,438 shares in its portfolio. Rhumbline Advisers reported 122,996 shares. Amer Century accumulated 1.44 million shares. Moreover, Cap Impact Advsr Limited Liability Co has 0.62% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 22,590 shares. Delta Asset Mgmt Ltd Llc Tn owns 26 shares or 0% of their US portfolio. Comerica Bancshares holds 0.03% or 56,522 shares. State Of Wisconsin Investment Board has 141,400 shares for 0.02% of their portfolio. Hightower Ltd Liability Com owns 13,049 shares or 0.01% of their US portfolio. State Common Retirement Fund invested 0.07% in Medidata Solutions, Inc. (NASDAQ:MDSO). Panagora Asset Mgmt owns 0% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 8,026 shares. Polen Capital Limited Liability accumulated 4,640 shares. Brown Cap Management Limited Liability Corp reported 4.11% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO). Menta Capital Lc holds 0.11% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO) for 9,106 shares. Tortoise Inv Management Ltd has invested 0% in Medidata Solutions, Inc. (NASDAQ:MDSO).

Since December 19, 2017, it had 0 insider buys, and 10 insider sales for $5.59 million activity. Another trade for 2,000 shares valued at $132,600 was sold by Bergmann Rouven. Another trade for 26,836 shares valued at $1.88 million was sold by de Vries Glen Michael. Otner Michael I. also sold $728,170 worth of Medidata Solutions, Inc. (NASDAQ:MDSO) shares.

Medidata Solutions (NASDAQ:MDSO) Rating Reaffirmed

Recently, In a research report revealed to clients on Wednesday, 23 May, Medidata Solutions (NASDAQ:MDSO) shares have had their Buy Rating maintained by equity research analysts at Piper Jaffray, who currently has a $98.0000 target price on firm. This target by Piper Jaffray suggests the possibile upside of 28.66 % from the last price.

Medidata Solutions, Inc. (NASDAQ:MDSO) Ratings Coverage

Among 10 analysts covering Medidata Solutions (NASDAQ:MDSO), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Medidata Solutions has $8900 highest and $68.0 lowest target. $81’s average target is 6.34% above currents $76.17 stock price. Medidata Solutions had 11 analyst reports since December 1, 2017 according to SRatingsIntel. On Thursday, May 10 the stock rating was maintained by Dougherty with “Buy”. The company was downgraded on Monday, May 21 by Morgan Stanley. On Friday, December 8 the stock rating was initiated by Deutsche Bank with “Buy”. KeyBanc Capital Markets maintained the shares of MDSO in report on Wednesday, January 3 with “Buy” rating. The firm has “Buy” rating by SunTrust given on Monday, January 22. The firm has “Buy” rating by Piper Jaffray given on Thursday, February 8. As per Friday, December 1, the company rating was upgraded by Wells Fargo. Needham maintained the stock with “Buy” rating in Friday, April 20 report. Morgan Stanley maintained the shares of MDSO in report on Friday, February 9 with “Overweight” rating. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) earned “Hold” rating by RBC Capital Markets on Thursday, February 8.

The stock increased 0.85% or $0.64 during the last trading session, reaching $76.17. About 557,205 shares traded. Medidata Solutions, Inc. (NASDAQ:MDSO) has risen 13.38% since May 23, 2017 and is uptrending. It has outperformed by 1.83% the S&P500.

Analysts await Medidata Solutions, Inc. (NASDAQ:MDSO) to report earnings on July, 17. They expect $0.22 EPS, up 22.22 % or $0.04 from last year’s $0.18 per share. MDSO’s profit will be $13.02 million for 86.56 P/E if the $0.22 EPS becomes a reality. After $0.24 actual EPS reported by Medidata Solutions, Inc. for the previous quarter, Wall Street now forecasts -8.33 % negative EPS growth.

Medidata Solutions, Inc. provides cloud solutions for life sciences worldwide. The company has market cap of $4.51 billion. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. It has a 102.93 P/E ratio. The companyÂ’s platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments.

More recent Medidata Solutions, Inc. (NASDAQ:MDSO) news were published by: Globenewswire.com which released: “Report: Exploring Fundamental Drivers Behind Gartner, F5 Networks, Medidata Solutions, Evertec, Ring Energy, and …” on May 15, 2018. Also Seekingalpha.com published the news titled: “Premarket analyst action – healthcare” on May 21, 2018. Benzinga.com‘s news article titled: “Benzinga’s Top Upgrades, Downgrades For May 21, 2018” with publication date: May 21, 2018 was also an interesting one.

Medidata Solutions, Inc. (NASDAQ:MDSO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: